Table 2 Patient characteristics for stereotactic radiation therapy prostate cancer patients (NCCN = National comprehensive Cancer Network)
From: Implementation of a comprehensive clinical quality assurance system in radiation oncology
# of patients | ||
|---|---|---|
Total | 209 | |
Consent for scientific analysis | Approved Unknown | 161 48 |
ECOG | 0 1 2 Unknown | 164 28 2 15 |
Histology | Adenocarcinoma Unknown | 208 1 |
T-stage | T1 T1a T1b T1c T2 T2a T2b T2c T3 T3a T3b Not assessed | 10 2 1 33 28 32 12 41 6 14 13 17 |
N-stage | 0 | 209 |
M-stage | 0 | 209 |
NCCN risk group | Very low Low Favorable Intermediate Unfavorable Favorable High Very high Unknown | 3 3 88 34 42 33 6 |